First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors
pictilisib (GDC-0941) 是一种强效泛 I 类磷脂酰肌醇-3-激酶 (PI3K) 抑制剂，在晚期实体肿瘤患者中开展的首次人体 I 期研究
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-14-0947
Debashis Sarker #, Joo Ern Ang #, Richard Baird, Rebecca Kristeleit, Krunal Shah, Victor Moreno, Paul A Clarke, Florence I Raynaud, Gallia Levy, Joseph A Ware, Kathryn Mazina, Ray Lin, Jenny Wu, Jill Fredrickson, Jill M Spoerke, Mark R Lackner, Yibing Yan, Lori S Friedman, Stan B Kaye, Mika K Derync
